Celldex Therapeutics Files 8-K on Financials
Ticker: CLDX · Form: 8-K · Filed: May 8, 2025 · CIK: 744218
| Field | Detail |
|---|---|
| Company | Celldex Therapeutics, Inc. (CLDX) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: CDLX
TL;DR
Celldex dropped an 8-K on May 8th covering their financials. Check it out.
AI Summary
Celldex Therapeutics, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Hampton, New Jersey.
Why It Matters
This filing provides investors with an update on Celldex Therapeutics' financial performance and operational status, which is crucial for evaluating the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any new material events or significant negative news.
Key Players & Entities
- Celldex Therapeutics, Inc. (company) — Registrant
- May 8, 2025 (date) — Date of earliest event reported
- Hampton, New Jersey (location) — Address of Principal Executive Offices
- AVANT IMMUNOTHERAPEUTICS INC (company) — Former Company Name
- T CELL SCIENCES INC (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Celldex Therapeutics, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 8, 2025.
Where are Celldex Therapeutics, Inc.'s principal executive offices located?
Celldex Therapeutics, Inc.'s principal executive offices are located at Perryville III Building, 53 Frontage Road, Suite 220, Hampton, New Jersey 08827.
What is Celldex Therapeutics, Inc.'s Commission File Number?
Celldex Therapeutics, Inc.'s Commission File Number is 000-15006.
Has Celldex Therapeutics, Inc. had previous names?
Yes, Celldex Therapeutics, Inc. was formerly known as AVANT IMMUNOTHERAPEUTICS INC (name change date 19980828) and T CELL SCIENCES INC (name change date 19920703).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Celldex Therapeutics, Inc. (CLDX).